Q3 2015 Holdings
Filed 2015-11-16 | 158 holdings | $21.8M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2015-11-17) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $5.8M | 218,679 | 26.4% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $5.6M | 957,193 | 25.6% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $2.6M | 851,200 | 11.7% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $2.5M | 260,000 | 11.5% |
| Champions Oncology Inc(CSBR) | COM NEW | 15870P307 | $2.0M | 372,597 | 9.1% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $1.4M | 123,745 | 6.5% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $761.0K | 19,256 | 3.5% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $175.6K | 14,439,444 | 0.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $117.1K | 2,942,967 | 0.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $89.4K | 2,784,928 | 0.4% |
| Retrophin Inc | COM | 761299106 | $53.6K | 2,647,080 | 0.2% |
| Tesaro Inc | COM | 881569107 | $39.4K | 981,759 | 0.2% |
| Global Blood Therapeutics in | COM | 37890U108 | $38.9K | 921,800 | 0.2% |
| Dyax Corp | COM | 26746E103 | $31.4K | 1,646,315 | 0.1% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $28.2K | 606,811 | 0.1% |
| GW PharmaceuticalsPut | ADS | 36197T103 | $27.4K | 300,000 | 0.1% |
| PTC Therapeutics Inc(PTCT)Put | COM | 69366J200 | $26.8K | 1,005,000 | 0.1% |
| Versartis Inc | COM | 92529L102 | $26.7K | 2,317,954 | 0.1% |
| Ishares Russell 2000(IWM)Put | RUSSELL 2000 ETF | 464287655 | $21.8K | 200,000 | 0.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $21.5K | 1,754,784 | 0.1% |
| Acelrx Pharmaceuticals Inc(ACRXUSD) | COM | 00444T100 | $19.1K | 6,264,060 | 0.1% |
| Relypsa Inc | COM | 759531106 | $18.3K | 987,942 | 0.1% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $18.2K | 654,515 | 0.1% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $17.2K | 779,213 | 0.1% |
| Streettracks Spdr Biotec ETF(XBI)Put | S&P BIOTECH | 78464A870 | $17.1K | 275,000 | 0.1% |
| Lion Biotechnologies Inc | COM | 53619R102 | $17.0K | 2,955,456 | 0.1% |
| Ignyta Inc | COM | 451731103 | $17.0K | 1,931,600 | 0.1% |
| Cempra Inc | COM | 15130J109 | $16.2K | 582,500 | 0.1% |
| Pfenex Inc | COM | 717071104 | $14.6K | 971,043 | 0.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $14.1K | 690,269 | 0.1% |
| Proshares Ultra S & P500(SSO)Put | PSHS ULT S&P 500 | 74347R107 | $11.1K | 200,000 | 0.1% |
| Capital SR Living Corp | COM | 140475104 | $11.1K | 553,600 | 0.1% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $11.0K | 472,000 | 0.1% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $10.9K | 306,715 | 0.1% |
| Novo-Nordisk A/S(NVO)Put | ADR | 670100205 | $10.8K | 200,000 | 0.0% |
| Quotient LTD | SHS | G73268107 | $10.3K | 776,803 | 0.0% |
| Gilead Sciences Inc(GILD)Put | COM | 375558103 | $9.8K | 100,000 | 0.0% |
| Acadia Pharmaceuticals Inc | COM | 4225108 | $9.8K | 295,240 | 0.0% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $9.6K | 300,000 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $9.4K | 742,858 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $9.1K | 123,044 | 0.0% |
| Teva Pharmaceutical Inds LTD(TEVA) | ADR | 881624209 | $9.0K | 160,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $8.6K | 404,404 | 0.0% |
| VBI Vaccines Inc | COM | 91790E102 | $8.6K | 3,260,356 | 0.0% |
| Shire PLC | SPONSORED ADR | 82481R106 | $8.4K | 41,000 | 0.0% |
| Zynerba Pharmaceuticals Inc | COM | 98986X109 | $8.3K | 579,350 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $7.8K | 371,066 | 0.0% |
| Assembly Biosciences Inc | COM | 45396108 | $7.6K | 795,000 | 0.0% |
| Bellicum Pharmaceuticals Inc | COM | 79481107 | $7.6K | 521,188 | 0.0% |
| Neptune Technologies Bioreso | COM | 64077P108 | $7.4K | 6,700,444 | 0.0% |